Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 3/20 | 1.00 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.76 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.76 |
| ▸ | EGFR | P00533 | 12/20 | 0.74 |
| ▸ | KDR | P35968 | 9/20 | 0.70 |
| ▸ | RET | P07949 | 7/20 | 0.68 |
| ▸ | GAK | O14976 | 3/20 | 0.68 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.68 |
| ▸ | STK10 | O94804 | 1/20 | 0.68 |
| ▸ | FLT3 | P36888 | 1/20 | 0.68 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.68 |
| ▸ | Q6ZSR9 | Q6ZSR9 | 1/20 | 0.68 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.68 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.68 |
| ▸ | RPS6KA6 | Q9UK32 | 1/20 | 0.68 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.68 |
| ▸ | KIF5B | P33176 | 5/20 | 0.67 |
| ▸ | SRC | P12931 | 2/20 | 0.67 |
| ▸ | LCK | P06239 | 3/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL323445 | 1.00 | JAK3 (1.00) | JAK3MKNK1ABCG2ABCB1EGFR | |
| SCHEMBL5864733 | 0.88 | JAK3 (0.79) | JAK3MKNK1ABCG2ABCB1EGFR | |
| SCHEMBL29372372 | 0.86 | JAK3 (1.00) | JAK3MKNK1ABCG2ABCB1EGFR | |
| SCHEMBL29651 | 0.86 | JAK3 (1.00) | JAK3MKNK1ABCG2ABCB1EGFR | |
| SCHEMBL29711485 | 0.86 | JAK3 (1.00) | JAK3MKNK1ABCG2ABCB1EGFR | |
| SCHEMBL7119275 | 0.85 | JAK3 (0.74) | JAK3MKNK1ABCG2EGFRKDR | |
| SCHEMBL5570070 | 0.84 | EGFR (0.85) | JAK3MKNK1ABCG2ABCB1EGFR | |
| SCHEMBL5864555 | 0.84 | KDR (0.73) | JAK3MKNK1EGFRKDRRET | |
| SCHEMBL6668470 | 0.84 | JAK3 (0.73) | JAK3MKNK1EGFRKDRRET | |
| SCHEMBL5467825 | 0.82 | EGFR (1.00) | JAK3MKNK1ABCG2ABCB1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4629993-A1 | METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS | Kartos Therapeutics (US) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| WO-2024124240-A1 | METHODS OF TREATING MYELOPROLIFERATIVE NEOPLASMS | KARTOS THERAPEUTICS (US) | 2024-06-13 | — | — | WO | disclosed |